Nurse practitioner-led program to help hospitalized smokers quit
Implementing Effective Smoking Cessation Pharmacotherapy for Hospitalized Smokers With Cardiopulmonary Disease
This study tests a program led by nurse practitioners to help hospitalized smokers with heart and lung issues quit smoking by using better medications and support.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Enrollment | 424 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Baystate Medical Center Academic / other |
| Locations | 1 site (Springfield, Massachusetts) |
| Trial ID | NCT05733767 on ClinicalTrials.gov |
What this trial studies
This study evaluates a nurse practitioner-led tobacco treatment team aimed at improving smoking cessation pharmacotherapy among hospitalized patients with cardiopulmonary conditions. Patients admitted to Baystate Medical Center who smoke will be screened and randomized into either enhanced usual care or the intervention group. The primary goal is to increase the use of guideline-concordant smoking cessation medications and improve smoking cessation rates at six months post-discharge. The study will recruit 424 patients to assess the effectiveness of this intervention.
Who should consider this trial
Good fit: Ideal candidates are hospitalized patients at Baystate Medical Center with a diagnosis of a cardiopulmonary condition who smoke cigarettes.
Not a fit: Patients who are pregnant, nursing, have suicidal ideation, or are expected to have a short life expectancy will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase smoking cessation rates among hospitalized patients, leading to improved health outcomes.
How similar studies have performed: Other studies have shown success with similar interventions aimed at smoking cessation in hospitalized patients, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Admitted to Baystate Medical Center in Springfield, MA with a cardiac or pulmonary disease diagnosis will be eligible to participate in this trial. * Patients who smoke cigarettes * Speak English We will include any patients with the following diagnoses or procedures from Baystate Medical Center in Springfield, MA: * myocardial infarction * coronary artery bypass grafting surgery * heart valve surgery * percutaneous coronary intervention (PCI) * acute coronary syndrome * heart failure * chronic obstructive pulmonary disease (COPD) * asthma exacerbation. Exclusion Criteria: * We will exclude pregnant or nursing women, patients with current suicidal ideation, planned discharge to hospice or expected survival \<6 months, or concurrent use of daily smoked marijuana, because this can increase exhaled carbon monoxide levels, which would confound biochemical confirmation.
Where this trial is running
Springfield, Massachusetts
- Baystate Medical Center — Springfield, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Quinn R Pack, MD — Baystate Medical Center
- Study coordinator: Quinn R Pack, MD
- Email: quinn.pack@baystatehealth.org
- Phone: 413-794-4490
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.